FIELD: pharmaceuticals; medicine.
SUBSTANCE: invention relates to a liquid pharmaceutical composition with anti-inflammatory, antiseptic and analgesic effects for the prevention and treatment of ENT organs and nasopharynx, containing octenidine hydrochloride, an anti-inflammatory agent selected from benzydamine, flurbiprofen or choline salicylate, and auxiliary substances in the following ratio of components, wt.%: octenidine hydrochloride 0.05–0.2; phenoxyethanol 0.5–1.5; benzydamine, or flurbiprofen, or choline salicylate 0.3–1.5; cocamidopropyl betaine 0.3–0.5; glycerol 2.5–7.0; sodium D-gluconate 0.4–0.7; water for injection up to 100.
EFFECT: wide range of antimicrobial action, fungicidal and virucidal activity of the pharmaceutical composition based on antiseptics and non-steroidal anti-inflammatory drugs, the absence of development of resistance of microorganisms to active substances, anti-inflammatory activity, rapid analgesic effect, accelerated healing of affected surfaces, safety.
6 cl, 1 dwg, 8 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR COMBATTING OTITIS MEDIA AND OTITIS EXTERNA | 2019 |
|
RU2749857C1 |
PHARMACEUTICAL COMPOSITION FOR TREATMENT OF INFECTIOUS AND INFLAMMATORY DISEASES | 2018 |
|
RU2749902C2 |
MEDICINAL PREPARATION IN THE FORM OF TABLETS FOR PREVENTION AND / OR TREATMENT OF CATARRHAL, ACUTE RESPIRATORY AND OTHER INFECTIOUS-INFLAMMATORY DISEASES OF THROAT AND ORAL CAVITY | 2020 |
|
RU2741388C1 |
TOPICAL AGENT FOR TREATING JOINT AND SOFT-TISSUE DISORDERS | 2013 |
|
RU2574008C2 |
DRUG FOR SYMPTOMATIC TREATMENT OF COLDS, ACUTE RESPIRATORY AND / OR OTHER INFECTIOUS AND INFLAMMATORY DISEASES OF THE THROAT | 2021 |
|
RU2773949C1 |
PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF BACTERIOLYTIC AND PROTEOLYTIC COMPLEX OF ENZYMES | 2016 |
|
RU2655808C2 |
PHARMACEUTICAL COMBINED COMPOSITION FOR LOCAL AND EXTERNAL USE ON BASIS OF DIOXIDINE | 2016 |
|
RU2667974C2 |
APPLICATION OF OCTENIDINE DIHYDROCHLORIDE IN SEMISOLID PREPARATIONS | 2006 |
|
RU2408372C2 |
TOPICAL USE OF DIOXIDIN FOR TREATMENT OF OTOLARYNGOLOGICAL DISEASES | 2022 |
|
RU2809120C1 |
ANTIFUNGAL AND ANTIMICROBIAL AGENT OF COMPLEX ACTION | 2018 |
|
RU2706115C1 |
Authors
Dates
2023-06-28—Published
2021-11-12—Filed